Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Gross Margin: 2016-2025

Historic Gross Margin for Collegium Pharmaceutical (COLL) over the last 9 years, with Sep 2025 value amounting to 61.70%.

  • Collegium Pharmaceutical's Gross Margin rose 94.00% to 61.70% in Q3 2025 from the same period last year, while for Sep 2025 it was 57.22%, marking a year-over-year decrease of 514.00%. This contributed to the annual value of 59.76% for FY2024, which is 221.00% up from last year.
  • According to the latest figures from Q3 2025, Collegium Pharmaceutical's Gross Margin is 61.70%, which was up 7.02% from 57.65% recorded in Q2 2025.
  • Collegium Pharmaceutical's Gross Margin's 5-year high stood at 63.38% during Q1 2021, with a 5-year trough of -4.87% in Q4 2021.
  • In the last 3 years, Collegium Pharmaceutical's Gross Margin had a median value of 58.75% in 2023 and averaged 58.58%.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Gross Margin tumbled by 6,294bps in 2021, and later spiked by 4,328bps in 2022.
  • Collegium Pharmaceutical's Gross Margin (Quarterly) stood at -4.87% in 2021, then skyrocketed by 4,328bps to 38.41% in 2022, then soared by 2,478bps to 63.19% in 2023, then slumped by 917bps to 54.02% in 2024, then surged by 94bps to 61.70% in 2025.
  • Its last three reported values are 61.70% in Q3 2025, 57.65% for Q2 2025, and 54.75% during Q1 2025.